Product Code: AST 3797
The global preparative and process chromatography market is projected to reach USD 21.50 billion by 2031 from USD 14.32 billion in 2026, growing at a CAGR of 8.2% during the forecast period.
| Scope of the Report |
| Years Considered for the Study | 2024-2031 |
| Base Year | 2025 |
| Forecast Period | 2025-2031 |
| Units Considered | Value (USD billion) |
| Segments | Product Type, Application, End User, and Region |
| Regions covered | North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
Vaccines and recombinant proteins using new modalities such as CGT, oligos, and mRNA are expected to grow in volume as demand for more personalized treatments rises in some developed economies. With increased volume, this diversity of biologics needs to be purified. These shifts make chromatography a critical unit operation, especially for capture and purification, creating space for market growth. The global monoclonal antibody (mAb) pipeline is expanding, marked by high FDA approvals and new bispecific and antibody-drug conjugate launches. This has helped boost purification requirements among end users, which is expected to increase the market for preparative and process chromatography products.
"Based on product type, process chromatography products held the largest share of the market in 2025."
Based on product, the preparative and process chromatography market is segmented into preparative chromatography and process chromatography. Process chromatography accounted for the largest share of the market. Global pharmaceutical and biopharmaceutical end users-which include major pharma facilities and CDMOs-are focused on commercial downstream workflows designed for process chromatography rather than preparative stages. New plants or large-scale manufacturing facilities drive recurring, multi-year demand for process resins, columns, and services. These factors helped process-scale chromatography products capture the largest share of the global market.
"Based on applications, the monoclonal antibodies and recombinant proteins segment held the largest share in 2025."
By application, the market for preparative and process chromatography is categorized into monoclonal antibodies & recombinant proteins, vaccines, peptides and oligonucleotides, cell and gene therapies, and other applications. The monoclonal antibodies & recombinant proteins production application acquired the largest market share in 2025. Monoclonal antibodies (mAbs) have become a widely adopted biotherapeutic modality across oncology, immunology, infectious disease, and rare disease indications. Regulatory pathways are well established, manufacturing processes are standardized, and biosimilar competition has driven market growth. Standardized, multi-step purification workflows drive consistent resin and consumables demand. The industry has converged on proven three-step chromatography trains for mAb purification: Protein A affinity capture (to isolate the target antibody from cell culture fluid), intermediate polishing (typically ion-exchange to remove aggregates and remaining impurities), and final polishing (to achieve specification-grade purity and remove residual ligands). These factors have helped the monoclonal antibodies & recombinant proteins production application segment acquire the largest share.
"Based on end user, the pharma and biopharma companies segment accounted for the largest share in 2025."
By end user, the preparative and process chromatography market is categorized into pharma & biopharma companies, food & nutraceutical companies, research & academia, and other end users. Pharma & biopharma companies held the largest share in 2024. Integrated pharmaceutical and biopharmaceutical manufacturers represent the anchor customer base for preparative and process chromatography, driven by their need to produce large-scale commercial biologics with consistent quality, high yield, and regulatory compliance. These organizations operate dedicated downstream facilities optimized for mAb, recombinant protein, and vaccine purification, requiring a continuous supply of resins, columns, systems, and technical support. Large pharma companies maintain in-house process development and manufacturing expertise and invest heavily in advanced chromatography platforms. The stability and scale of these operations, combined with their strict quality and regulatory requirements, make them a key end user segment with significant demand. These factors have helped them acquire the largest share.
"North America is expected to hold a significant share in the preparative and process chromatography market throughout the forecast period."
The preparative and process chromatography market comprises five main regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2025, North America held a significant share of the market for preparative and process chromatography products. Its dominant position stems from increased manufacturing capacity focused on both commercial-scale and clinical-trial supply production. Investment trends indicate that US federal and state support promotes domestic biomanufacturing for pandemic preparedness and to reduce reliance on international supply chains. Small- to mid-sized biotech firms are increasingly partnering with CDMOs. These factors helped North America secure the largest market share in 2025.
A breakdown of the primary participants referred to for this report is provided below:
- By Company Type: Tier 1 (35%), Tier 2 (45%), and Tier 3 (20%)
- By Designation: C-level Executives (35%), Directors (25%), and Others (40%)
- By Region: North America (40%), Europe (30%), Asia Pacific (20%), Latin America (5%), and the Middle East & Africa (5%)
The key players profiled in the preparative and process chromatography market are Danaher Corporation (US), Repligen Corporation (US), Merck KGaA (Germany), Thermo Fisher Scientific (US), Agilent Technologies, Inc. (US), Bio-Rad Laboratories, Inc. (US), Avantor, Inc. (US), Sartorius AG (Germany), Shimadzu Corporation (Japan), Ecolab Inc. (US), Tosoh Bioscience (Japan), Mitsubishi Chemical Group Corporation (Japan), Revvity (US), PerkinElmer (US), Cecil Instruments Limited (UK), W.R. Grace & Co. (US), Ecom SPO (Czech Republic), BUCHI Labortechnik AG (Switzerland), Good Science (Tianjin) Instrument Technologies Co., Ltd. (China), Bio Works Technologies (Sweden), Sykam GmbH (Germany), Sunresin New Materials Co., Ltd. (China), YMC Co., Ltd. (Japan), and Geno Technology Inc. (US)
Research Coverage
The research report analyzes the preparative and process chromatography market by product, application, end user, and region. It examines the factors driving market growth, the challenges and opportunities across industries, and the competitive landscape, including market leaders and small- to medium-sized enterprises. It also estimates revenue for different market segments across five regions and includes a micromarket analysis.
Reasons to Buy the Report
The report will help market leaders and new entrants by providing accurate revenue estimates for the entire preparative and process chromatography market and its subsegments. It will help stakeholders understand the competitive landscape, enabling them to position their businesses more effectively and develop suitable go-to-market strategies. Additionally, the report offers insights into market dynamics, including key drivers, restraints, challenges, and opportunities.
This report provides insightful data on the following.
- Market Penetration: In-depth coverage of product portfolios offered by the top players in the preparative and process chromatography market
- Product Development/Innovation: In-depth coverage of product portfolios offered by the top players in the preparative and process chromatography market
- Market Development: Insightful data on profitable developing areas
- Market Diversification: Details about recent developments and advancements in the preparative and process chromatography market
- Competitive Assessment: Extensive assessment of the products, growth tactics, revenue projections, and market categories of the top competitors
TABLE OF CONTENTS
1 INTRODUCTION
- 1.1 STUDY OBJECTIVES
- 1.2 MARKET DEFINITION
- 1.3 STUDY SCOPE
- 1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE
- 1.3.2 INCLUSIONS & EXCLUSIONS
- 1.3.3 YEARS CONSIDERED
- 1.4 CURRENCY CONSIDERED
- 1.5 STAKEHOLDERS
- 1.6 SUMMARY OF CHANGES
2 EXECUTIVE SUMMARY
- 2.1 MARKET HIGHLIGHTS & KEY INSIGHTS
- 2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS
- 2.3 DISRUPTIVE TRENDS IN PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET
- 2.4 HIGH-GROWTH SEGMENTS
- 2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST
3 PREMIUM INSIGHTS
- 3.1 PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET OVERVIEW
- 3.2 ASIA PACIFIC PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET, BY END USER AND COUNTRY
- 3.3 PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
4 MARKET OVERVIEW
- 4.1 INTRODUCTION
- 4.2 MARKET DYNAMICS
- 4.2.1 DRIVERS
- 4.2.1.1 Increased demand for complex biologics and advanced therapeutic modalities
- 4.2.1.2 Increased outsourcing to CDMOs
- 4.2.1.3 Technological advancements in chromatography media and systems
- 4.2.1.4 Need for cost optimization in downstream processing
- 4.2.2 RESTRAINTS
- 4.2.2.1 Lowered replacement rate due to incomplete single-use adoption
- 4.2.2.2 Limited resin lifetime and performance degradation
- 4.2.3 OPPORTUNITIES
- 4.2.3.1 Ongoing investments in bioprocessing capacity and analytical capabilities
- 4.2.3.2 Expansion of integrated, intensified, and continuous chromatography columns
- 4.2.4 CHALLENGES
- 4.2.4.1 Shortage of skilled chromatography professionals
- 4.2.4.2 High capital and operating costs
- 4.3 UNMET NEEDS
- 4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES
- 4.5 STRATEGIC MOVES BY TIER1/2/3 PLAYERS
- 4.5.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET
5 INDUSTRY TRENDS
- 5.1 PORTER'S FIVE FORCES ANALYSIS
- 5.1.1 BARGAINING POWER OF BUYERS
- 5.1.2 BARGAINING POWER OF SUPPLIERS
- 5.1.3 THREAT OF NEW ENTRANTS
- 5.1.4 THREAT OF SUBSTITUTES
- 5.1.5 INTENSITY OF COMPETITIVE RIVALRY
- 5.2 MACROECONOMIC INDICATORS
- 5.2.1 INTRODUCTION
- 5.2.2 GDP TRENDS & FORECAST
- 5.2.3 TRENDS IN GLOBAL BIOPROCESS INDUSTRY
- 5.3 SUPPLY CHAIN ANALYSIS
- 5.3.1 PROMINENT COMPANIES
- 5.3.2 SMALL & MEDIUM-SIZED ENTERPRISES
- 5.3.3 END USERS
- 5.4 VALUE CHAIN ANALYSIS
- 5.4.1 RESEARCH & PRODUCT DEVELOPMENT
- 5.4.2 RAW MATERIAL PROCUREMENT
- 5.4.3 MANUFACTURING
- 5.4.4 DISTRIBUTION, MARKETING & SALES, AND POST-SALES SERVICES
- 5.5 ECOSYSTEM ANALYSIS
- 5.6 PRICING ANALYSIS
- 5.6.1 AVERAGE SELLING PRICE OF PREPARATIVE AND PROCESS CHROMATOGRAPHY PRODUCTS, BY KEY PLAYER, 2025
- 5.6.2 AVERAGE SELLING PRICE OF PREPARATIVE AND PROCESS CHROMATOGRAPHY PRODUCTS, BY REGION, 2025
- 5.7 TRADE ANALYSIS
- 5.7.1 IMPORT DATA (HS CODE 902720)
- 5.7.2 EXPORT DATA (HS CODE 902720)
- 5.8 KEY CONFERENCES & EVENTS, 2026-2027
- 5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
- 5.10 INVESTMENT & FUNDING SCENARIO
- 5.11 CASE STUDY ANALYSIS
- 5.12 IMPACT OF 2025 US TARIFFS ON PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET
- 5.12.1 INTRODUCTION
- 5.12.2 KEY TARIFF RATES
- 5.12.3 PRICE IMPACT ANALYSIS
- 5.12.4 IMPACT ON COUNTRY/REGION
- 5.12.4.1 US
- 5.12.4.2 Europe
- 5.12.4.3 Asia Pacific
- 5.12.5 IMPACT ON END-USE INDUSTRIES
6 STRATEGIC DISRUPTIONS THROUGH TECHNOLOGY, PATENTS, AND DIGITAL & AI ADOPTION
- 6.1 KEY EMERGING TECHNOLOGIES
- 6.1.1 RECOMBINANT PROTEIN A LIGAND ENGINEERING
- 6.1.2 ALKALINE-STABLE LIGAND DEVELOPMENT
- 6.2 COMPLEMENTARY TECHNOLOGIES
- 6.2.1 AUTOMATED COLUMN PACKING SYSTEMS
- 6.2.2 IN-LINE MONITORING AND PAT (PROCESS ANALYTICAL TECHNOLOGY)
- 6.3 ADJACENT TECHNOLOGIES
- 6.3.1 CONTINUOUS CHROMATOGRAPHY SYSTEMS
- 6.3.2 AFFINITY MEMBRANE TECHNOLOGY
- 6.4 PATENT ANALYSIS
- 6.5 IMPACT OF AI ON PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET
- 6.5.1 TOP USE CASES & MARKET POTENTIAL
- 6.5.2 BEST PRACTICES IN PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET
- 6.5.3 CLIENTS' READINESS TO ADOPT GENERATIVE AI IN PREPARATIVE AND PROCESS CHROMATOGRAPHY
- 6.6 SUCCESS STORIES & REAL-WORLD APPLICATIONS
7 SUSTAINABILITY & REGULATORY LANDSCAPE
- 7.1 REGULATORY LANDSCAPE & SUSTAINABILITY INITIATIVES
- 7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- 7.1.2 REGULATORY TRENDS
- 7.1.2.1 North America
- 7.1.2.2 Europe
- 7.1.2.3 Asia Pacific
- 7.1.2.4 Rest of the World
- 7.2 INDUSTRY STANDARDS
- 7.2.1 SUSTAINABILITY INITIATIVES
- 7.2.2 IMPACT OF REGULATORY POLICIES ON SUSTAINABILITY INITIATIVES
8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR
- 8.1 DECISION-MAKING PROCESS
- 8.2 BUYER STAKEHOLDERS & BUYING EVALUATION CRITERIA
- 8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS
- 8.2.2 BUYING EVALUATION CRITERIA
- 8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES
- 8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
- 8.5 MARKET PROFITABILITY
9 PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET, BY PRODUCT TYPE
- 9.1 INTRODUCTION
- 9.2 PROCESS CHROMATOGRAPHY PRODUCTS
- 9.2.1 CHEMICALS & REAGENTS
- 9.2.1.1 Recurring consumption to drive demand for chemicals & reagents
- 9.2.2 RESINS
- 9.2.2.1 Increased purification volume to drive demand for resins
- 9.2.3 COLUMNS
- 9.2.3.1 Reproducible results and low cross-contamination risk to drive demand for columns in process chromatography operations
- 9.2.4 SYSTEMS
- 9.2.4.1 Less changeover time and maintenance needs to boost demand for single-use chromatography systems
- 9.2.5 AFTER-MARKET SERVICES
- 9.2.5.1 Capacity expansions and routine calibration needs to drive market growth
- 9.3 PREPARATIVE CHROMATOGRAPHY PRODUCTS
- 9.3.1 CHEMICALS & REAGENTS
- 9.3.1.1 Method development focus and high-purity results to drive market for reagents in preparative operations
- 9.3.2 RESINS
- 9.3.2.1 Cost-effective supply chain metrics to drive demand for bulk resins
- 9.3.3 COLUMNS
- 9.3.3.1 Flexibility, low sample consumption, and high throughput to drive adoption
- 9.3.4 SYSTEMS
- 9.3.4.1 Biologics innovation and strong mAb pipeline to support demand for systems
- 9.3.5 AFTER-MARKET SERVICES
- 9.3.5.1 Consultative and technical services to drive demand for after-market services
10 PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET, BY APPLICATION
- 10.1 INTRODUCTION
- 10.2 MONOCLONAL ANTIBODIES & RECOMBINANT PROTEINS
- 10.2.1 SHIFT TOWARDS MORE COST-EFFECTIVE OPTIONS TO OPEN NEW REVENUE CHANNELS
- 10.3 VACCINES
- 10.3.1 WIDE APPLICATION BASE OF STANDARDIZED CHROMATOGRAPHY TECHNIQUES IN VACCINE MANUFACTURING TO DRIVE MARKET GROWTH
- 10.4 PEPTIDES & OLIGONUCLEOTIDES
- 10.4.1 SHIFT TOWARDS HYBRID SYNTHESIS TO DRIVE MARKET GROWTH
- 10.5 CELL & GENE THERAPIES
- 10.5.1 LOWER TARGET PRODUCT YIELD TO HAMPER GROWTH OF CHROMATOGRAPHY AS PRIMARY TECHNIQUE
- 10.6 OTHER APPLICATIONS
11 PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET, BY END USER
- 11.1 INTRODUCTION
- 11.2 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES
- 11.2.1 EXTENSIVE USE IN BIOLOGICAL DRUG PRODUCTION TO ENSURE STRONG DEMAND
- 11.3 FOOD & NUTRACEUTICAL COMPANIES
- 11.3.1 EXPANDING USE CASES IN NUTRACEUTICAL INDUSTRY TO BOOST MARKET GROWTH
- 11.4 RESEARCH & ACADEMIC INSTITUTES
- 11.4.1 INCREASING R&D IN DRUG DISCOVERY TO DRIVE USE OF CHROMATOGRAPHY
- 11.5 OTHER END USERS
12 PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET, BY REGION
- 12.1 INTRODUCTION
- 12.2 NORTH AMERICA
- 12.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
- 12.2.2 US
- 12.2.2.1 Expansion in biomanufacturing and domestic capacity to drive market
- 12.2.3 CANADA
- 12.2.3.1 Policy-led capacity build and CDMO growth to drive market
- 12.3 EUROPE
- 12.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
- 12.3.2 GERMANY
- 12.3.2.1 Capacity expansion in end-use facilities to generate new demand channels for target products
- 12.3.3 UK
- 12.3.3.1 Government policies and public-private partnerships to drive market
- 12.3.4 FRANCE
- 12.3.4.1 Demand-side developments to add new revenue channels for chromatography OEMs and suppliers
- 12.3.5 ITALY
- 12.3.5.1 Increased CAPEX from major end-user categories to fuel demand for target products
- 12.3.6 SPAIN
- 12.3.6.1 Increased number of CDMOs and CROs to propel demand for chromatography and related products
- 12.3.7 REST OF EUROPE
- 12.4 ASIA PACIFIC
- 12.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
- 12.4.2 JAPAN
- 12.4.2.1 CDMO capacity expansions, policy backing, and CDMO investments to propel market
- 12.4.3 CHINA
- 12.4.3.1 Robust biopharmaceutical expansion to support demand
- 12.4.4 INDIA
- 12.4.4.1 Growth of pharma and biotech industries to drive demand for preparative and process chromatography
- 12.4.5 AUSTRALIA
- 12.4.5.1 Increasing demand for protein-based therapeutics to drive growth
- 12.4.6 SOUTH KOREA
- 12.4.6.1 Developments in biopharmaceutical sector to drive market growth
- 12.4.7 REST OF ASIA PACIFIC
- 12.5 LATIN AMERICA
- 12.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
- 12.5.2 BRAZIL
- 12.5.2.1 Biomanufacturing emphasis and public-private partnerships to catalyze demand
- 12.5.3 MEXICO
- 12.5.3.1 Supportive government initiatives to boost demand for preparative and process chromatography products
- 12.5.4 REST OF LATIN AMERICA
- 12.6 MIDDLE EAST & AFRICA
- 12.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
- 12.6.2 GCC COUNTRIES
- 12.6.2.1 Favorable government policies to propel market growth
- 12.6.3 REST OF MIDDLE EAST & AFRICA
13 COMPETITIVE LANDSCAPE
- 13.1 INTRODUCTION
- 13.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
- 13.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET
- 13.3 REVENUE ANALYSIS, 2020-2024
- 13.4 MARKET SHARE ANALYSIS, 2025
- 13.4.1 MARKET RANKING OF KEY PLAYERS, 2025
- 13.5 COMPANY VALUATION & FINANCIAL METRICS
- 13.5.1 FINANCIAL METRICS
- 13.5.2 COMPANY VALUATION
- 13.6 BRAND/PRODUCT COMPARISON
- 13.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
- 13.7.1 STARS
- 13.7.2 EMERGING LEADERS
- 13.7.3 PERVASIVE PLAYERS
- 13.7.4 PARTICIPANTS
- 13.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
- 13.7.5.1 Company footprint
- 13.7.5.2 Region footprint
- 13.7.5.3 Product type footprint
- 13.7.5.4 Application footprint
- 13.7.5.5 End-user footprint
- 13.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
- 13.8.1 PROGRESSIVE COMPANIES
- 13.8.2 RESPONSIVE COMPANIES
- 13.8.3 DYNAMIC COMPANIES
- 13.8.4 STARTING BLOCKS
- 13.8.5 COMPETITIVE BENCHMARKING OF STARTUPS/SMES, 2025
- 13.8.5.1 Detailed list of key startups/SMEs
- 13.8.5.2 Competitive benchmarking of key startups/SMEs
- 13.9 COMPETITIVE SCENARIO
- 13.9.1 PRODUCT LAUNCHES
- 13.9.2 DEALS
- 13.9.3 EXPANSIONS
14 COMPANY PROFILES
- 14.1 KEY PLAYERS
- 14.1.1 DANAHER
- 14.1.1.1 Business overview
- 14.1.1.2 Products offered
- 14.1.1.3 Recent developments
- 14.1.1.3.1 Product launches
- 14.1.1.3.2 Deals
- 14.1.1.3.3 Expansions
- 14.1.1.4 MnM view
- 14.1.1.4.1 Right to win
- 14.1.1.4.2 Strategic choices
- 14.1.1.4.3 Weaknesses & competitive threats
- 14.1.2 THERMO FISHER SCIENTIFIC INC.
- 14.1.2.1 Business overview
- 14.1.2.2 Products offered
- 14.1.2.3 Recent developments
- 14.1.2.3.1 Deals
- 14.1.2.3.2 Expansions
- 14.1.2.4 MnM view
- 14.1.2.4.1 Right to win
- 14.1.2.4.2 Strategic choices
- 14.1.2.4.3 Weaknesses & competitive threats
- 14.1.3 MERCK KGAA
- 14.1.3.1 Business overview
- 14.1.3.2 Products offered
- 14.1.3.3 Recent developments
- 14.1.3.3.1 Deals
- 14.1.3.3.2 Expansions
- 14.1.3.3.3 Other developments
- 14.1.3.4 MnM view
- 14.1.3.4.1 Right to win
- 14.1.3.4.2 Strategic choices
- 14.1.3.4.3 Weaknesses & competitive threats
- 14.1.4 SARTORIUS AG
- 14.1.4.1 Business overview
- 14.1.4.2 Products offered
- 14.1.4.3 MnM view
- 14.1.4.3.1 Right to win
- 14.1.4.3.2 Strategic choices
- 14.1.4.3.3 Weaknesses & competitive threats
- 14.1.5 WATERS CORPORATION
- 14.1.5.1 Business overview
- 14.1.5.2 Products offered
- 14.1.5.3 Recent developments
- 14.1.5.3.1 Product launches
- 14.1.5.3.2 Deals
- 14.1.5.4 MnM view
- 14.1.5.4.1 Right to win
- 14.1.5.4.2 Strategic choices
- 14.1.5.4.3 Weaknesses & competitive threats
- 14.1.6 AGILENT TECHNOLOGIES, INC.
- 14.1.6.1 Business overview
- 14.1.6.2 Products offered
- 14.1.6.3 Recent developments
- 14.1.6.3.1 Product launches
- 14.1.6.3.2 Deals
- 14.1.6.3.3 Expansions
- 14.1.7 AVANTOR, INC.
- 14.1.7.1 Business overview
- 14.1.7.2 Products offered
- 14.1.8 BIO-RAD LABORATORIES, INC.
- 14.1.8.1 Business overview
- 14.1.8.2 Products offered
- 14.1.9 REPLIGEN CORPORATION
- 14.1.9.1 Business overview
- 14.1.9.2 Products offered
- 14.1.9.3 Recent developments
- 14.1.9.3.1 Product launches
- 14.1.9.3.2 Deals
- 14.1.10 SHIMADZU CORPORATION
- 14.1.10.1 Business overview
- 14.1.10.2 Products offered
- 14.1.10.3 Recent developments
- 14.1.11 ECOLAB INC.
- 14.1.11.1 Business overview
- 14.1.11.2 Products offered
- 14.1.11.3 Recent developments
- 14.1.11.3.1 Product launches
- 14.1.11.3.2 Deals
- 14.1.11.3.3 Expansions
- 14.1.12 TOSOH BIOSCIENCE
- 14.1.12.1 Business overview
- 14.1.12.2 Products offered
- 14.1.12.3 Recent developments
- 14.2 OTHER PLAYERS
- 14.2.1 MITSUBISHI CHEMICAL CORPORATION
- 14.2.2 REVVITY
- 14.2.3 PERKINELMER
- 14.2.4 CECIL INSTRUMENTS LIMITED
- 14.2.5 W. R. GRACE & CO.-CONN
- 14.2.6 ECOM SPOL. S R.O
- 14.2.7 BUCHI LABORTECHNIK AG
- 14.2.8 GOOD SCIENCE (TIANJIN) INSTRUMENT TECHNOLOGIES CO., LTD.
- 14.2.9 BIO WORKS TECHNOLOGIES
- 14.2.10 SYKAM GMBH
- 14.2.11 SUNRESIN NEW MATERIALS CO. LTD.
- 14.2.12 YMC CO., LTD.
- 14.2.13 GENO TECHNOLOGY INC.
15 RESEARCH METHODOLOGY
- 15.1 RESEARCH DATA
- 15.1.1 SECONDARY RESEARCH
- 15.1.1.1 Key secondary sources
- 15.1.1.2 Key data from secondary sources
- 15.1.1.3 Objectives of secondary research
- 15.1.2 PRIMARY RESEARCH
- 15.1.2.1 Key primary sources
- 15.1.2.2 Key supply- and demand-side participants
- 15.1.2.3 Breakdown of primary interviews
- 15.1.2.4 Objectives of primary research
- 15.1.2.5 Key primary insights
- 15.2 MARKET SIZE ESTIMATION
- 15.2.1 BOTTOM-UP APPROACH
- 15.2.1.1 Company revenue estimation
- 15.2.1.2 Customer-based market estimation
- 15.2.1.3 Primary interviews
- 15.2.2 TOP-DOWN APPROACH
- 15.3 GROWTH RATE ASSUMPTIONS
- 15.4 DATA TRIANGULATION
- 15.5 STUDY ASSUMPTIONS
- 15.6 RESEARCH LIMITATIONS
- 15.7 RISK ANALYSIS
16 APPENDIX
- 16.1 DISCUSSION GUIDE
- 16.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
- 16.3 CUSTOMIZATION OPTIONS
- 16.4 RELATED REPORTS
- 16.5 AUTHOR DETAILS